250 related articles for article (PubMed ID: 35458467)
1. Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation.
Poletto F; Spiezia L; Simion C; Campello E; Dalla Valle F; Tormene D; Camporese G; Simioni P
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458467
[TBL] [Abstract][Full Text] [Related]
2. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
3. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
Hasan SS; Radford S; Kow CS; Zaidi STR
J Thromb Thrombolysis; 2020 Nov; 50(4):814-821. PubMed ID: 32748122
[TBL] [Abstract][Full Text] [Related]
5. Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
Adomi M; Kuno T; Komiyama J; Taniguchi Y; Abe T; Miyawaki A; Imai S; Morita K; Saito M; Ohbe H; Kamio T; Tamiya N; Iwagami M
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):680-688. PubMed ID: 35324035
[TBL] [Abstract][Full Text] [Related]
6. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes.
Al-Dorzi HM; Alqirnas MQ; Hegazy MM; Alghamdi AS; Alotaibi MT; Albogami MT; Alhafi MM; Alwadani S; Elsharkawi A; Arabi YM
J Crit Care Med (Targu Mures); 2022 Oct; 8(4):249-258. PubMed ID: 36474613
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
Lee Y; Jehangir Q; Li P; Gudimella D; Mahale P; Lin CH; Apala DR; Krishnamoorthy G; Halabi AR; Patel K; Poisson L; Balijepally V; Sule AA; Nair GB
BMC Infect Dis; 2022 May; 22(1):462. PubMed ID: 35562677
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia.
Go RC; Nyirenda T; Bojarian M; Hosseini DK; Rahim M; Kim K; Rose KM
BMC Pulm Med; 2022 Jan; 22(1):6. PubMed ID: 34986821
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis.
Vedovati MC; Graziani M; Agnelli G; Becattini C
Intern Emerg Med; 2023 Apr; 18(3):863-877. PubMed ID: 36580269
[TBL] [Abstract][Full Text] [Related]
15. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
[TBL] [Abstract][Full Text] [Related]
18. Venous Thromboembolism in Hospitalized COVID-19 Patients.
Sridharan GK; Vegunta R; Rokkam VRP; Meyyur Aravamudan V; Vegunta R; Khan SR; Ponnada S; Boregowda U; Prudhvi K; Chamarthi G; Mohan BP
Am J Ther; 2020; 27(6):e599-e610. PubMed ID: 33156016
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients.
Mei F; Fan J; Yuan J; Liang Z; Wang K; Sun J; Guan W; Huang M; Li Y; Zhang WW
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2332-2337. PubMed ID: 32628040
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
